Inventor

ADAMS GREGORY P

US11 patents

⚠️ This page may combine multiple inventors who share the name “ADAMS GREGORY P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ADAMS GREGORY P

4 patents

US8580263B2Nov 12, 2013

Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof

ADAMS GREGORY P20 citations90

US8329873B2Dec 11, 2012

Bispecific single chain Fv antibody molecules and methods of use thereof

ADAMS GREGORY P28 citations90

US8198411B2Jun 12, 2012

Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer

ADAMS GREGORY P2 citations55

US9611321B2Apr 4, 2017

Rationally-designed anti-mullerian inhibiting substance type II receptor antibodies

ADAMS GREGORY P1 citations45

UNIV CALIFORNIA

2 patents

US7332580B2Feb 19, 2008

Bispecific single chain Fv antibody molecules and methods of use thereof

UNIV CALIFORNIA76 citations96

US8980258B2Mar 17, 2015

Bispecific single chain Fv antibody molecules and methods of use therof

UNIV CALIFORNIA1 citations61

MUSCULOSKELETAL TRANSPLANT FOUNDATION

2 patents

USD856517SAug 13, 2019

Asymmetric tissue graft

MUSCULOSKELETAL TRANSPLANT FOUNDATION30 citations91

US10945831B2Mar 16, 2021

Asymmetric tissue graft

MUSCULOSKELETAL TRANSPLANT FOUNDATION3 citations67

CALIFORNIA UNIVERSITY

1 patent

US7332585B2Feb 19, 2008

Bispecific single chain Fv antibody molecules and methods of use thereof

CALIFORNIA UNIVERSITY60 citations94

FOX CHASE CANCER CT

1 patent

US7781568B2Aug 24, 2010

Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer

FOX CHASE CANCER CT2 citations56

THE RES INSTITUTE OF FOX CHASE CANCER CENTER

1 patent

US11261225B2Mar 1, 2022

Chimera of bone morphogenic protein 2 and the Müllerian-inhibiting substance type II receptor binding region of Müllerian-inhibiting substance

THE RES INSTITUTE OF FOX CHASE CANCER CENTER0 citations43